SEL-212
Selecta Biosciences
[]
new treatment target for #gout #eular2023 sel-212 - 2 drugs one after the other! - tolerogenic nanoparticles containing rapamycin followed by pegadricase
-only 50% reponded, but there were pts who didn't respond at all. 
Rheumatologist @HSpecialSurgery @WeillCornell ClinicalResearch | Big Data | Outcomes | Epidemiology | Disparities | Table tennis player | Tweets are my own.